HUM stock forecast: what analysts expect
Wall Street analysts covering Humana Inc. currently rate the stock a Buy on average, with a mean 12-month price target of $416.43 — +7.1% versus the last price of $388.83. Targets reflect analyst opinion, not a guarantee.
HUM historical returns
Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in HUM.
HUM annual returns by year
Congress trading in HUM
9 members of Congress have disclosed trading HUM — 4 purchases and 10 sales worth an estimated $178,501. Most recent disclosure: Feb 10, 2026.
See who in Congress traded HUM →About Humana Inc.
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
HUM Key Statistics
HUM in plain English
- P/E ratio (35.2) — how many dollars you pay for each $1 of HUM's yearly profit. That's a fairly normal range.
- ROE (6.89%) — how efficiently the company turns shareholders' money into profit. This is a middling level.
- Profit margin (0.88%) — of every $1 in sales, this is what's left as profit after all costs.
- Dividend yield (0.95%) — the cash payout you'd earn per year as a % of the share price, on top of any price gains.
HUM stock: frequently asked questions
What is Humana Inc.'s stock price today?
Humana Inc. (HUM) last traded at $388.83 on the NYSE. Over the past 52 weeks the stock has traded between $163.11 and $428.88.
Is HUM stock a buy or a sell?
Wall Street analysts' consensus rating on HUM is "Buy", with an average 12-month price target of $416.43 — about +7.1% versus the current price of $388.83. Analyst targets are opinions, not guarantees; always do your own research.
How much would $1,000 invested in HUM 10 years ago be worth today?
A $1,000 investment in Humana Inc. made 10 years ago would be worth about $2,368 today (dividends reinvested) — a total return of 137%, or 9.0% per year.
Does HUM pay a dividend?
Yes. Humana Inc. currently pays a dividend yielding about 0.95% per year at today's share price.
What is HUM's P/E ratio?
HUM trades at a trailing price-to-earnings ratio of 35.2, and 23.5 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.
Do members of Congress trade HUM stock?
Yes — 9 members of Congress have disclosed trades in HUM under the STOCK Act, totaling 4 purchases and 10 sales worth an estimated $178,501.
What is Humana Inc.'s ticker symbol?
Humana Inc. trades under the ticker symbol HUM on the NYSE.
Compare HUM with peers
Data last refreshed from public sources. Figures may be delayed. Not investment advice.